Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$393,419
+$117,081 QoQ
Shares Held
7,508
-3.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#262
of 421 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026New Age Alpha Advisors, LLC holds $14,948,777 across 10 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
22,262 | $3,752,037 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,267 | $3,395,648 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
19,974 | $2,215,915 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
52,689 | $1,826,727 | |
| 5 | ZTS |
Zoetis Inc.
|
22,671 | $1,629,138 | |
| 6 | PRGO |
PERRIGO Co plc
|
106,665 | $1,108,249 | |
| 7 | ALKS |
Alkermes plc.
This page
|
7,508 | $393,419 | |
| 8 | VTRS |
Viatris Inc
|
21,038 | $334,083 |
All Filings in ALKS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $393,419 | 7,508 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $276,338 | 7,815 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $224,287 | 8,016 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $408,990 | 13,633 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $397,993 | 13,911 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $452,440 | 13,702 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $170,748 | 5,937 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||